This is a report published in the Lancet Oncology, one of the leading medical journals on cancer research. It is the first study of its level “to show significant clinical benefit after previously targeting the bESR1 mutation”
A new study revealed that it is possible to stop the progression of certain breast cancers, through early detection of a genetic mutation in the heart of the tumors and adapting the treatment accordingly.
The report was published in the Lancet Oncology, one of the leading cancer journals. It is the first study of its level “to show significant clinical benefit after previously targeting the bESR1 mutation.”
*Also read: Falls in Colombia network dedicated to the alteration of medicines from Venezuela
In breast cancer, tumor cells evolve over time and, depending on certain mutations, can become resistant to the treatments used. For this reason, in many cases, the most aggressive diagnoses become immune to drugs.
A technique that could slow the progression of cancer allows to detect this mutation, and in the study they used a technique that has shown promise in recent years: the “liquid biopsy”.
Post Views:
466
